Work

Phase II Trial of Weekly Bortezomib in Combination with Rituximab in Relapsed or Relapsed/Refractory Waldenstrom's Macroglobulinemia.

Year: 2009

Type: article

Study design: Clinical Trial

Source: Blood

DOI: 10.1182/blood.v114.22.2727.2727

Authors: Irene M. Ghobrial, Fangxin Hong, Swaminathan Padmanabhan, Ashraf Z. Badros, Meghan Rourke, Renee Leduc, Stacey Chuma, Janet Kunsman, Diane Warren, Brianna Harris, Amy Sam, Kenneth C. Anderson, Paul Richardson, M.D., Steven Treon, Edie Weller, Jeffrey Matous

Institutions: Dana-Farber Cancer Institute, Roswell Park Comprehensive Cancer Center, University of Maryland, Baltimore, University of Maryland Marlene and Stewart Greenebaum Comprehensive Cancer Center, Harvard University, Dana-Farber/Harvard Cancer Center, Rocky Mountain Cancer Centers

Language: English

Topic: Chronic Lymphocytic Leukemia Research

Subfield: Genetics

Field: Medicine

Domain: Health Sciences

SDG: Good health and well-being

Open Access status: closed

OpenAlex ID: W2554569362

FWCI: 0.289

Cites: 27

Cited by: 5

Related to: 10